-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA INC - FOLLOWING THE COMPLETION OF DOSE COHORT, DSMB TO REVIEW STUDY DATA FOR SAFETY AND EFFICACY

Reuters·11/03/2025 13:00:08

Please log in to view news